Routine

Smoking cessation (tobacco dependence; stop-smoking support, NRT & pharmacotherapy)

Preventive / behavioural · Geriatric & General
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Smoking is the single largest preventable cause of death. Every clinical contact is an opportunity to deliver very brief advice and offer evidence-based support, which combines behavioural support with pharmacotherapy and roughly triples quit success versus willpower alone. Use the 'Ask-Advise-Act' (or 5As) model. Pharmacotherapy options include nicotine replacement therapy (combination preferred), varenicline, bupropion and, increasingly, nicotine-containing vapes as a harm-reduction/cessation aid.

Red flags

  • New/worsening low mood, agitation or suicidal thoughts on varenicline/bupropion — review (also consider nicotine withdrawal and underlying depression)
  • Seizure history — avoid bupropion
  • Red-flag respiratory symptoms (haemoptysis, weight loss) — investigate for lung cancer, do not just advise cessation
  • Chest pain in a smoker — assess cardiac cause

Assessment

Differential diagnosis

  • Assess dependence: time to first cigarette (within 30 min = higher dependence), number per day, previous quit attempts (Fagerstrom/Heaviness of Smoking Index)
  • Identify comorbidity influencing choice: pregnancy, mental illness, cardiovascular disease, COPD
  • Other tobacco/nicotine: smokeless tobacco, bidis, hookah (relevant in India), vaping

Investigations

  • Smoking history: pack-years, dependence level, triggers, prior attempts and what helped/failed
  • Exhaled carbon monoxide (CO) monitoring where available to assess and motivate
  • Screen for and optimise smoking-related disease (COPD/spirometry, CVD risk) and mental-health comorbidity
  • No routine bloods required for cessation itself

Management

  • ASK about smoking at every contact and record status
  • ADVISE: deliver clear, personalised very brief advice that the best thing for health is to stop, and that support makes it much more likely to succeed
  • ACT: offer referral to a stop-smoking service and offer pharmacotherapy — do not just advise 'cut down'
  • Agree a quit date; combine behavioural support (local service, telephone, app) with pharmacotherapy
  • Offer combination NRT (long-acting patch + short-acting lozenge/gum/inhalator/spray) as first-line, or varenicline, or a nicotine-containing vape; start before or on the quit date per drug
  • Address weight-gain concerns, withdrawal symptoms and relapse triggers; plan follow-up in the first weeks (highest relapse risk)
  • In pregnancy: behavioural support first-line; offer NRT if needed (avoid varenicline/bupropion); CO monitoring
  • Follow up to reinforce, manage side effects, and treat relapse as part of the process (most quitters need several attempts)

Drugs & doses

Nicotine replacement therapy — combination (first-line): nicotine patch 21 mg/24 h (or 15 mg/16 h) PLUS a fast-acting form as needed (lozenge/gum 2-4 mg, inhalator, or mouth/nasal spray); titrate to dependence [verify local dose]
Varenicline 0.5 mg PO once daily days 1-3, 0.5 mg twice daily days 4-7, then 1 mg twice daily; start 1-2 weeks before quit date, 12-week course (monitor mood; nausea common) [verify local dose]
Bupropion (amfebutamone) 150 mg PO once daily for 3 days then 150 mg twice daily, start 1-2 weeks before quit date (contraindicated in seizure/eating disorders; lowers seizure threshold) [verify local dose]
Nicotine-containing vape (e-cigarette) as a harm-reduction/cessation aid in adults who smoke (not for never-smokers/pregnancy) [verify local]
Cytisine (cytisinicline) where available — low-cost plant-based option, dosing per schedule [verify local dose]

Disposition

Outpatient / opportunistic. Refer to local stop-smoking service; follow up early to support the quit attempt and manage pharmacotherapy. Treat relapse by re-offering support.

Complications & pitfalls

  • Nicotine withdrawal: irritability, craving, poor concentration, low mood, increased appetite/weight gain, insomnia
  • Relapse (the norm, not failure — plan re-attempts)
  • Drug effects: NRT skin reactions/palpitations, varenicline nausea/vivid dreams, bupropion insomnia/seizure risk

Exam pearls

  • Very brief advice (Ask-Advise-Act) takes under a minute and is one of the most cost-effective interventions in medicine.
  • Behavioural support + pharmacotherapy roughly triples quit rates versus willpower alone.
  • Combination NRT (patch + short-acting) is more effective than a single product; varenicline is among the most effective single agents.
  • A nicotine-containing vape is more effective than NRT for some smokers and is endorsed for harm reduction, but not for never-smokers or in pregnancy.
  • Treat relapse as expected — most people need several attempts; keep offering support.
  • Guidance: NICE NG209 (tobacco) and PHE/OHID; in India also address bidis, smokeless tobacco and gutkha.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.